d as vice president of business operations earlier this year. His more than 14 years of experience, primarily in the pharmaceutical and life sciences industries, include corporate development, strategic planning, project management and investor and public relations, with extensive transaction experience. Previously, Mr. Eso served as manager of corporate development at Agilent Technologies, where he helped execute strategic transactions across all businesses, including acquisitions, partnerships and alliances, joint ventures, in-licensing and investments, and divestitures. Prior to joining Agilent, Mr. Eso served as director of corporate development at Peregrine Pharmaceuticals, the parent company of Avid. Previously, he served as manager of corporate development and senior investor relations analyst at Watson Pharmaceuticals.
"It has been gratifying to work with the Avid team during the past months as the company has continued to achieve impressive gains," said Mr. Eso. "I look forward to building on this foundation over the coming years and partnering with Truc and the entire Avid team to further reinforce Avid's stature as a primary supplier of choice by helping to expand our business offerings, develop a variety of new strategic relationships and partnerships, implement process improvements and grow our business in adjacent new markets."
Earlier in his career, Mr. Eso held positions of increasing responsibility at various companies, including Allergan and the Professional Golfers' Association (PGA). Mr. Eso holds a B.A. in communications, public relations from California State University, Fullerton and an M.B.A. from Concordia University, Irvine.
Avid Bioservices is a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM).
About Avid Bi
Page: 1 2 3 4 5 Related biology technology :1
|SOURCE Avid Bioservices, Inc.|
Copyright©2009 PR Newswire.
All rights reserved
. ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody2
. Avid Bioservices Expands Capabilities With Installation of Innovative Thermo Scientific HyClone Single-Use Bioreactor Systems3
. Avid Bioservices Presents Data From Manufacturing Successes Achieved With Single-Use Bioreactor Systems4
. Paragon Bioservices, Inc. Wins 2009 Lilly Global Supplier Award5
. ATS Medical Expands Open Pivot Heart Valve Offerings6
. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility7
. BioLife Solutions Expands Scientific Advisory Board8
. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability9
. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment10
. Pharsight Expands Strategic Consulting Services Team11
. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)